Molecular epidemiology of hepatitis B virus in Dakar, Sénégal

Journal of Medical Virology

Volumn 78, Issue 3, 2006, Pages 329-334

  Vray, Muriel ^a   Debonne, Jean Marc ^b   Sire, Jean Marie ^c   Tran, Nathalie ^d   Chevalier, Benoit ^b   Plantier, Jean Christophe ^e   Fall, Fatou ^b   Vernet, Guy ^d   Simon, François ^c,e   Saliou Mb, Papa ^b  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

^d BIOMÉRIEUX   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Africa; DNA chips; Genotype; HBV; Pre core mutant; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS DELTA ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; CHRONIC HEPATITIS; DNA MICROARRAY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENEGAL; VIRUS CHARACTERIZATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ALANINE TRANSAMINASE; BLOOD DONORS; CODON, NONSENSE; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C; HEPATITIS D; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; SENEGAL; VIRAL LOAD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 33644661561     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20544     Document Type: Article

References (24)

1. Blackberg J, Kidd-Ljunggren K. 2000. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe. J Med Virol 60:107-112.
2. Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, Yvonnet B, Diouf C, Denis F, Diop-Mar I, Correa P. 1984. Immune response to hepatitis B vaccine in infants and newborns: Control trial in an endemic area (Sénégal). IARC Sci Publ 63:319-335.
3. Dumpis U, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P. 2001. Prevalence of HBV core/precore/core mutations in Gambian chronic carrier. J Med Virol 65:664-670.
4. Etard JT, Colbachini P, Dromigny JA, Perrier-Gros-Claude JD. 2001. Hepatitis C antibodies among blood donors, Sénégal. Emerg Infect Dis 9:1492-1493.
5. Evans AA, O'Connell AP, Pugh JC, Mason WS, Shen FM, Chen GC, Lin WY, Dia A, M'Boup S, Drame B, London WT. 1998. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 7:559-565.
6. Fung SK, Lok AS. 2004. Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection? Hepatology 40:790-792.
7. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. 2004. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2:87-106.
8. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. 2005. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol 75:513-521.
9. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R. 2004. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39:211-219.
10. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. 1993. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region. J Virol 67:5402-5410.
11. Lindh M, Andersson AS, Gusdal A. 1997. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175:1285-1293.
12. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum JJ, Nebie YK, Maiga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. 2004. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190:400-408.
13. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
14. Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ. 2005. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine. Hepatology 42:121-129.
15. Perrin A, Duracher D, Perret M, Cleuziat P, Mandrand B. 2003. A combined oligonucleotide and protein microarray for the codetection of nucleic acids and antibodies associated with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections. Anal Biochem 15; 322:148-155.
16. Rizzetto M, Tassopoulos NC, Goldin RD, Esteban R, Santantonio T, Heathcote EJ, Lagget M, Taak NK, Woessner MA, Gardner SD. 2005. Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatology 42:173-179.
17. Rouet F, Chaix ML, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, ANRS 1236 DITRAME-B&C Study Group. 2004. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. J Med Virol 74:34-40.
18. Sail Diallo A, Sarr M, Fall Y, Diagne C, Kane MO. 2004. Hepatitis B infection in infantile population of Senegal. Dakar Med 49:136-142.
19. Shin JW, Chung YH, Choi MH, Kim JA, Ryu SH, Jang MK, Kim IS, Park NH, Lee HC, Lee YS, Suh DJ. 2000. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy. J Med Virol 60:107-112.
20. Simpore J, Granato M, Santarelli R, Nsme RA, Coluzzi M, Pietra V, Pignatelli S, Bere A, Faggioni A, Angeloni A. 2004. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 31:78-80.
21. Stelzl E, Muller Z, Marth E, Kessler HH. 2004. Rapid quantification of hepatitis B virus DNA by automated sample preparation and real-time PCR. J Clin Microbiol 42:2445-2449.
22. Suzuki S, Sugauchi F, Orito E, Kato H, Usuda S, Siransy L, Arita I, Sakamoto Y, Yoshihara N, El-Gohary A, Ueda R, Mizokami M. 2003. Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: Complete genome sequence and phylogenetic relatedness of HBV genotype E. J Med Virol 69:459-465.
23. Thakur V, Sarin SK, Rehman S, Guptan RC, Kazim SN, Kumar S. 2005. Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol 24:12-15.
24. Wai CT, Chu CJ, Hussain M, Lok AS. 2002. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 36:1425-1430.